2009•China Medical HeraldRequires access

Clinical efficacy and safety of Ceftazidime Injection in children with bacterial lower respiratory infection

Juan Wu

Open publisher page 0 citations

Abstract

Objective:To evaluate the clinical efficacy and safety of Ceftazidime Injection in Children with bacterial lower respiratory infection.Methods:Cefoperazone/Sulbactam sodium(Sulperazon) as a control drug and 180 cases of children tested in randomized controlled trials.98 cases of the test group given Ceftazidime 60 mg/(kg·d) were intravenous infused twice, 82 cases of the control group given Sulperazon 50 mg/(kg·d) were intravenous injected twice, regimens for 7 days.Results:The efficiency of the test group and control group were 92.86% and 90.24%.The bacterial clearance rate of the test group was 88.24%, it was higher than the control group(85.94%).Adverse effect rate of the two groups were 7.14% and 7.32%, there was no significant difference(P0.05).Conclusion:Ceftazidime Injection has a good efficacy and safety for treatment of bacterial lower respiratory infection in children, there is a high clinical value.

About this research paper

What this paper is about

Objective:To evaluate the clinical efficacy and safety of Ceftazidime Injection in Children with bacterial lower respiratory infection.Methods:Cefoperazone/Sulbactam sodium(Sulperazon) as a control drug and 180 cases of children tested in randomized controlled trials.98 cases of the test group given Ceftazidime 60 mg/(kg·d) were intravenous infused twice, 82 cases of the control group given Sulperazon 50 mg/(kg·d) were intravenous injected twice, regimens for 7 days.Results:The efficiency of the test group and control group were 92.86% and 90.24%.The bacterial clearance rate of the test group was 88.24%, it was higher than the control group(85.94%).Adverse effect rate of the two groups were 7.14% and 7.32%, there was no significant difference(P0.05).Conclusion:Ceftazidime Injection has a good efficacy and safety for treatment of bacterial lower respiratory infection in children, there is a high clinical value.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the clinical efficacy and safety of Ceftazidime Injection in Children with bacterial lower respiratory infection.Methods:Cefoperazone/Sulbactam sodium(Sulperazon) as a control drug and 180 cases of children tested in randomized controlled trials.98 cases of the test group given Ceftazidime 60 mg/(kg·d) were intravenous infused twice, 82 cases of the control group given Sulperazon 50 mg/(kg·d) were intravenous injected twice, regimens for 7 days.Results:The efficiency of the test group and control group were 92.86% and 90.24%.The bacterial clearance rate of the test group was 88.24%, it was higher than the control group(85.94%).Adverse effect rate of the two groups were 7.14% and 7.32%, there was no significant difference(P0.05).Conclusion:Ceftazidime Injection has a good efficacy and safety for treatment of bacterial lower respiratory infection in children, there is a high clinical value.

Key concepts: Medicine, Ceftazidime, Cefoperazone, Adverse effect, Anesthesia, Clinical efficacy, Respiratory system, Sulbactam

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical efficacy and safety of Ceftazidime Injection in children with bacterial lower respiratory infection — Research Paper | ScholarLens